About Us

in.vent Clin­i­cal Ser­vices is a spe­cial­ist depart­ment of in.vent Diag­nos­ti­ca GmbH, Europe’s lead­ing experts for human biosam­ple procurement.

We assist our clients in the plan­ning, set­up, con­duct, and eval­u­a­tion of stud­ies with in-vit­ro diag­nos­tic devices (IVDs). Our ser­vices cov­er all project phas­es from start to fin­ish, comprising:

  • Study design and planning
  • Eth­i­cal and reg­u­la­to­ry clearance
  • Sam­ple sourcing
  • Sam­ple analysis
  • Data man­age­ment and analysis
  • Report­ing

The extent of these ser­vice ele­ments is defined by your indi­vid­ual require­ments. Small pre-admis­sion stud­ies are cov­ered just as com­plete IVDR-com­pli­ant clin­i­cal per­for­mance stud­ies.
State-of-the-art IVD val­i­da­tion means that the study design is based on the intend­ed pur­pose of the respec­tive prod­uct. This requires a high lev­el of indi­vid­u­al­i­sa­tion when it comes to sam­ple sourc­ing, the con­trol of pre-ana­lyt­i­cal con­di­tions, or the choice of a com­para­tor device.
Our process­es are tai­lored to meet these demands. While being embed­ded in an ISO 9001 and ISO 13485 cer­ti­fied qual­i­ty man­age­ment sys­tem, we main­tain a high lev­el of flex­i­bil­i­ty and are not lim­it­ed to a spe­cif­ic med­ical field. This allows us to com­ply with the study design require­ments of all kinds of IVD devices, be it point-of-care or lab-based, intend­ed for pro­fes­sion­als or layper­sons, pathogen-screen­ing, preg­nan­cy, blood para­me­ter quan­tifi­ca­tion or any other.

Grafik ICS Clinical Services Okt 2023 Entwurf 1

Study designs are as indi­vid­ual as IVD devices and their intend­ed pur­pos­es. Every detail of study design – par­tic­u­lar­ly sam­ple size cal­cu­la­tion – can have a huge impact on fea­si­bil­i­ty as well as price and lead time. The very first step of any val­i­da­tion project is there­fore the pre­cise def­i­n­i­tion of the product’s intend­ed pur­pose and a cor­re­spond­ing study design.

IVDR and ISO 20916 express clear expec­ta­tions regard­ing con­tent and struc­ture of a per­for­mance study plan. We can gen­er­ate the study plan for you or you may approach us with a study plan your­self. Either way, we will take care that the sub­mit­ted study plan is com­pli­ant with all applic­a­ble guidelines.

Per­for­mance stud­ies with human spec­i­mens must be approved by ethics com­mit­tees or insti­tu­tion­al review boards (IRBs) and in some cas­es also a gov­ern­men­tal author­i­ty. This require­ment can be time-con­sum­ing, espe­cial­ly when for­mal errors result in addi­tion­al review ses­sions. Learn more.

Our sam­ples come from sources that cor­re­spond to your product’s intend­ed pur­pose; as demand­ed by the IVDR. The sam­ple col­lec­tions we organ­ise and mon­i­tor take place in hos­pi­tals, med­ical prac­tices, blood dona­tion cen­tres, or nurs­ery homes, specif­i­cal­ly fol­low­ing the indi­vid­ual require­ments of your prod­uct. Learn more.

Donor recruit­ment entails the gen­er­a­tion of patient infor­ma­tion and informed con­sent forms that must sat­is­fy the good prac­tice pro­vi­sions of the nation­al ethics boards. Being in direct con­tact with the study par­tic­i­pants calls for the respon­si­bil­i­ty that par­tic­i­pants are kept informed and that their safe­ty and dig­ni­ty is main­tained through­out the study process. This is par­tic­u­lar­ly the case in lon­gi­tu­di­nal stud­ies with mul­ti­ple dona­tions from the same donors.

Suit­able donors for a study can be rare, so max­i­mum care must be giv­en that sam­ples main­tain the high­est pos­si­ble qual­i­ty between col­lec­tion and analy­sis. Apply­ing the right pre-ana­lyt­i­cal con­di­tions at every step is key. Avoid­ing addi­tion­al obsta­cles such as pro­longed delay in cus­toms dur­ing inter­na­tion­al stud­ies requires an expe­ri­enced logis­tics team.

Sam­ple analy­sis gen­er­ates the data that the whole study revolves around. The sam­ples that have been col­lect­ed for this pur­pose are often used up the process. Hence, any mis­takes and impre­ci­sions must be kept to an absolute min­i­mum. The require­ments for guar­an­tee­ing this dif­fer great­ly between val­i­da­tions of point-of-care devices and lab devices.

Mon­i­tor­ing is not only required by IVDR and ISO 20916 but is also an essen­tial means of con­trol over data qual­i­ty, espe­cial­ly dur­ing inter­na­tion­al stud­ies. The most well writ­ten study plan or inves­ti­ga­tor brochure may be mis­in­ter­pret­ed by study nurs­es or inves­ti­ga­tors. Check­ing remote­ly or on-site whether all process­es are imple­ment­ed and exe­cut­ed as intend­ed, is vital for a suc­cess­ful study project.

The gen­er­a­tion of clin­i­cal data is the pri­ma­ry goal of any study, so dili­gent man­age­ment of it is anoth­er cor­ner stone in this process. The allo­ca­tion and repro­ducibil­i­ty of blind­ed sam­ple IDs to left­over sam­ples, source data, and reports must be guar­an­teed for decades of archiving.

Sta­tis­ti­cal analy­ses are required at the very begin­ning and the very end of a study. At the begin­ning, a thor­ough sta­tis­ti­cal assess­ment of a suit­able sam­ple size is already a deci­sive mile­stone that will be reviewed by IRBs, gov­ern­men­tal author­i­ties, and noti­fied bod­ies. At the end of the study, bio­sta­tis­tics will trans­late the raw data points into the per­for­mance para­me­ters that your prod­uct will be judged upon.

Our final deliv­er­able to you will be the study report togeth­er with the raw data. Our reports are gen­er­at­ed fol­low­ing guide­lines and stan­dards such as STARD 2015 and ISO 20916.

If suit­able for your device, stud­ies can be con­duct­ed in our com­pa­ny-owned study cen­tre, which allows a max­i­mum of con­trol over all process­es. In all oth­er cas­es, we prof­it from our vast glob­al net­work of col­lab­o­ra­tion part­ners. Our stud­ies can take place in Europe, South Amer­i­ca, Africa, or East Asia, always accord­ing to your needs and our qual­i­ty standards.

ICS is every­thing you need for your val­i­da­tion study in one sin­gle ser­vice pack­age. All in one.

Connect with our experts

in per­son to explore cut­ting-edge inno­va­tions and part­ner­ships that dri­ve suc­cess in health­care. Don’t miss your chance to meet us and stay at the fore­front of the indus­try. Your jour­ney to supe­ri­or health­care solu­tions starts here!

Join us in person at upcoming events!

Med­lab 2024
AACC 2024
Med­ica 2024